Inflammation
Study results from Sun Yat-Sen University update understanding of inflammation
Published in Drug Week, January 15th, 2010
"Proopiomelanocortin (POMC) is the precursor of anti-inflammatory melanocortins, which have been proposed of therapeutic potential for various inflammatory diseases. The present study aimed to evaluate whether peripheral POMC expression ameliorated capsaicin-induced acute neurogenic inflammation in rat trachea. Prophylactic POMC expression was achieved by intravenous injection of adenovirus encoding POMC (Ad-POMC), which led to POMC...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-01-15)
More Articles from Drug Week
- American Academy of Neurology
Guideline: Widely used device for pain therapy not recommended for chronic low back pain - American Associates, Ben-Gurion University of the Negev
Anti-inflammatory drugs coxibs interfere with aspirin's clotting ability -- Ben-Gurion U. - Institute for Research in Biomedicine IRB Barcelona
Researchers design a tool to induce controlled suicide in human cells - JAMA and Archives Journals
Findings suggest cardiovascular devices often approved by FDA without high-quality studies - Journal of the National Cancer Institute
Assessing lead time of selected ovarian cancer biomarkers - Journal of the National Cancer Institute
News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
